Company profile
High Force Research Limited
High Force Research - Chemical Research and Development
Independent CRO / CDMO addressing a range of chemistry requirements across multiple industries. API Manufacture for Pre-clinical and Clinical Supply with GMP
Corporate ownership
Updated 06 Jun 2026 16:52
Latest accounts
Financial period: 1 Jul 2023 to 30 Jun 2024
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Confirmation Statement With No Updates
Confirmation-statementCS01 | Transaction MzQ0MjYyMTM0OGFkaXF6a2N4
Published 11 Nov 2024 10:46
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQ0MjA2MjA3NmFkaXF6a2N4
Published 05 Nov 2024 03:40
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
UK Manufacture of Key Reagents for RT-PCR Testing
1 Jun 2020 to 30 Nov 2020
Nucleosides and nucleotides are the building blocks of DNA and RNA and play a pivotal role in DNA replication, transcription and translation, whilst their chemistry constitutes a vibrant field of research for both synthetic and biological chemists. They remain one of the most fruitful drug classes, with nucleosides providing keys structural components for...
Sustainable manufacturing of waterborne polymers for high performance Decorative paints
1 Feb 2013 to 31 Jan 2016
This project, orchestrated by ICI Paints, part of the AkzoNobel Group of Companies, involves the development of several novel approaches to reducing, and preferably eliminating, solvents in paints. The project involves a partnership between ICI Paints, an SME (High Force Research) and academic institutions (Durham and Manchester), working together to deve...
Multi stage approach to scale up for fast and slow reactions
1 May 2011 to 31 Jul 2011
Awaiting Public Summary